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ABSTRACT
Background MRI-visible perivascular spaces (PVS) are
potential neuroimaging markers of cerebral small vessel
disease, but their functional signiﬁcance and
mechanisms remain uncertain. We investigated the
association between PVS and cognitive impairment, and
other MRI markers of small vessel disease, in a patient
cohort of ischaemic stroke/transient ischaemic attack
(TIA) referrals.
Methods Data were collected from a prospective
observational database. Standardised detailed
neuropsychological testing was performed. A validated
visual rating scale on T2-weighted MRI was used to
categorise PVS severity; validated scales were used to
assess white matter hyperintensities (WMH), cerebral
microbleeds (CMB) and lacunes.
Results We included 246 patients (45.1% female,
mean age 62 years). No signiﬁcant association between
PVS severity grade in any brain region and impairment in
any cognitive domain was identiﬁed. In multivariable
analysis, WMH and hypertension (but not age) were
independently associated with basal ganglia PVS severity
(OR: 1.27; p<0.0001 and OR: 4.89; p=0.013,
respectively). Increasing PVS severity in the basal ganglia
was associated with lacunar stroke subtype (p<0.0001).
Age and hypertension (but not WMH or lacunar stroke
subtype) were independently associated with centrum
semiovale PVS severity (OR: 1.19; p=0.013 and OR:
3.71; p=0.007, respectively).
Conclusions PVS do not have an independent
association with cognitive impairment in patients with
ischaemic stroke or TIA. The associations with clinical-
radiological factors are consistent with the hypothesis
that PVS reﬂect cerebral small vessel disease; the
different associations for basal ganglia and centrum
semiovale PVS might indicate different underlying small
vessel arteriopathies according to PVS anatomical
distribution, but this requires further study.
INTRODUCTION
Cerebral small vessel disease (SVD) is a highly
prevalent cause of stroke and cognitive impair-
ment,1 but its pathophysiology is incompletely
understood.2 MRI-visible perivascular spaces (PVS)
are emerging as promising new neuroimaging
markers of SVD.3 PVS have been independently
associated to incident dementia4 and cognitive
function in a healthy elderly population.5 However,
their relationship with cognition in patients with
cerebrovascular disease, in whom cognitive impair-
ment is very common, is largely unknown.6
The pathophysiological mechanisms underlying
PVS also remain unclear. The two commonest spor-
adic forms of SVD are: ﬁrst, an intrinsic process
affecting deep (basal ganglia, deep white matter
and brainstem) small perforating arteries, and given
a number of terms including arterioloscerosis, lipo-
hyalinosis or ﬁbrinoid necrosis, but generally con-
sidered at least partly related to hypertension, so
for simplicity, often termed hypertensive arteriopa-
thy; and, second, cerebral amyloid angiopathy
(CAA). The former has a predilection for the deep
perforating arteries (basal ganglia and brainstem),
while CAA typically affects cortical and leptomen-
ingeal vessels.7 These processes may plausibly lead
to different anatomical patterns of PVS.8
We hypothesised that: (A) since PVS reﬂect SVD,
PVS severity is associated with worse cognitive
function, particularly in speed-attention and frontal
executive cognitive domains; and (B) PVS severity
in basal ganglia and centrum semiovale is associated
with clinical-radiological markers of SVD and
stroke subtype, but associations may be different
depending on PVS location. We therefore investi-
gate associations between PVS and cognitive func-
tion in an ischaemic stroke/transient ischaemic
attack (TIA) patient population. We also investi-
gated associations of PVS with other clinical-
radiological markers of SVD and ischaemic stroke
subtype.
METHODS
Subjects
Patients admitted to the stroke unit, or attending
the neurovascular clinic at the National Hospital
for Neurology and Neurosurgery, Queen Square,
London, who were referred for neuropsychological
testing (2000–2007) were considered for inclusion.
Provided there are no contraindications, all stroke
service patients are referred for neuropsychological
testing and MRI scanning in this service (ﬁgure 1).
The stroke, or TIA mechanism, was determined
using the results of a detailed diagnostic assessment
and were classiﬁed into aetiologies as per the Trial
of Org 10172 in Acute Stroke (TOAST)
guidelines.9
Neuropsychological assessment
A standardised neuropsychological battery examin-
ing seven cognitive domains (current intellectual
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functioning, verbal and visual memory, nominal, perceptual,
frontal executive and speed and attention functions) was carried
out by a neuropsychologist blinded to the patients’ clinical and
MRI data. For patient-dependent reasons, not all patients were
administered identical sets of tests, as decided by the neuro-
psychologist (see online supplementary material A). Premorbid
IQ was assessed using the National Adult Reading Test (NART).
Patients were classiﬁed as being impaired or unimpaired in each
cognitive domain using predeﬁned standardised criteria.10
MRI rating
Images were analysed by a trained observer blinded to clinical
ﬁndings. Lacunes were deﬁned as deep infarcts measuring
3–20 mm, seen as well-deﬁned hypointensities on T1-weighted
and ﬂuid attenuated inversion recovery (FLAIR) images.11 white
matter hyperintensities (WMH) were rated using a validated
scale.12 Cerebral microbleeds were deﬁned according to standar-
dised criteria on T2*-weighted sequences, and rated using the
Microbleed Anatomical Rating Scale (MARS).13 PVS were rated
by a trained observer using a validated visual rating scale11; they
were deﬁned as small (<3 mm), sharply delineated structures
(dots or linear structures) of cerebrospinal ﬂuid intensity on
axial T2-weighted MRI (TR/TE=6000/102 ms) following the
orientation of perforating cerebral small vessels.14 Lacunes were
distinguished form PVS by their larger size (>3 mm), spheroid
shape and surrounding hyperintensity on FLAIR. In the
centrum semiovale and basal ganglia, patients were grouped
into <10, 11–20, 21–40 and >40 PVS (see online supplemen-
tary material B for further details of MRI criteria and footnote
of ﬁgure 1 for MRI strength and sequences).
Statistical analysis
Due to the small number of PVS and the lack of evidence of
clinical signiﬁcance of <10 PVS, the ﬁrst and second PVS
groups (0 and 1–10 PVS) were merged (<10 PVS group).
Pearson’s χ2 or Kruskal–Wallis one-way analysis of variance,
were used as appropriate to evaluate signiﬁcant differences in
variables between PVS groups. The χ2 test for trend was used to
Figure 1 Flow diagram showing the patient exclusion criteria. NHNN, National Hospital for Neurology and Neurosurgery. GRE, gradient echo
sequence; FLAIR, ﬂuid attenuated inversion recovery; ICH, intracerebral haemorrhage; TBI, traumatic brain injury; PACS, picture archiving and
communication system. *MRI parameters and sequences. MRIs were carried out on a 1.5 Tesla Signa Echospeed system (General Electric,
Milwaukee, USA). The sequences included axial T2-weighted fast spin echo sequence (TR/TE=6000/102 ms), axial T2*-weighted GRE sequence
(TR=300 ms; ET=40 ms; ﬂip angle: 20; ﬁeld of view: 24×18; matrix: 256×160, TR/TE=300/40 ms), a sagittal T1-weighted sequence, and a coronal
FLAIR sequence (TR/TI/TE=9895/2473/140 ms). Five patients had MRI using similar sequences on a 1.5 Tesla Siemens Avanto MRI scanner. For all
these sequences, slice thickness was 5 mm and slice gap 1.5 mm.
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establish direct linear correlations. Univariable ordinal logistic
regression was used to test for the association between PVS
severity categories and impairment in cognitive domains. We
considered any p value <0.05 to be signiﬁcant.
Ordinal logistic regression analyses were used to identify pre-
dictors of increasing PVS severity in the centrum semiovale and
basal ganglia. Multivariable analysis was conducted controlling
for variables found to be signiﬁcant in the univariable analysis
and likely to have pathophysiological inﬂuence on PVS.
Statistical analysis was conducted on Stata 10.0 (StataCorp LP,
Texas, USA).
The study was approved by the National Hospital for
Neurology and Neurosurgery and Institute of Neurology joint
research ethics committee.
RESULTS
The ﬁnal cohort consisted of 246 patients; their baseline charac-
teristics are reported online supplementary material C. The
mean age was 62.0 years (SD: 16.5 years) and 45.1% of the
patients were women. A diagnosis of hypertension was present
in 68.2% of the patients. The baseline characteristics, including
gender and median premorbid IQ score, did not differ across
different PVS categories.
Prevalence of PVS
The proportions of patients in each PVS category are shown in
online supplementary material C. There was a lower prevalence
of PVS in the basal ganglia compared to the centrum semiovale
and midbrain (80.5% vs 99.6% and 87.7%, respectively). There
was higher prevalence of more severe PVS grades in the
centrum semiovale, compared with the basal ganglia (see online
supplementary material D). There was no signiﬁcant association
between basal ganglia and centrum semiovale severity categories
(data not shown). There were no signiﬁcant differences in the
prevalence and severity of PVS between TIA and ischaemic
stroke patients (data not shown).
Cognitive domain analysis
In unadjusted ordinal logistic regression analysis for clinical and
imaging predictors of cognitive impairment in all seven cognitive
domains, WMH were signiﬁcantly associated with impaired per-
ceptual skills (p=0.03) and speed and attention (p=0.001).
Lobar microbleeds were associated with impaired frontal execu-
tive function (p=0.05). No signiﬁcant association between PVS
severity grade in any brain region and impairment in any cogni-
tive domain was identiﬁed (see online supplementary material E).
The lack of a signiﬁcant effect between PVS severity and
cognition remained consistent in a sensitivity analysis excluding
patients with TIA. Recurrent stroke was not associated with
cognitive impairment in any domains in univariable analysis.
Factors associated with increased PVS severity
Univariable analysis demonstrated that age (p<0.0001), hyper-
tension (p<0.0001), median WMH score (p<0.0001), lacunes
presence (p=0.01, p<0.0001), CMBs (p=0.04, p=0.001) and
lobar CMBs (p=0.05, p=0.03) were signiﬁcant predictors for
both centrum semiovale and basal ganglia PVS severity, respect-
ively (see online supplementary material F). The presence of
deep CMBs was a signiﬁcant predictor of PVS severity only in
the basal ganglia (OR 6.14; 95% CI 2.81 to 13.47, p<0.0001).
Recurrent stroke was not associated with increased PVS severity
in any location.
In multivariable analysis, WMH and hypertension (but not
age) were independently associated with basal ganglia PVS
severity (OR: 1.27; p<0.0001 and OR: 4.89; p=0.013, respect-
ively; table 1). Age and hypertension (but not WMH) were
independently associated with centrum semiovale PVS severity
(OR: 1.19; p=0.013 and OR: 3.71; p=0.007, respectively;
table 1). Increasing PVS severity in the basal ganglia, but not the
centrum semiovale, was associated with lacunar stroke subtype
(p<0.0001). No variables were associated with severity of mid-
brain PVS (data not shown).
DISCUSSION
Our data suggest that PVS do not have an independent associ-
ation with cognitive impairment in this population, but we con-
solidate and extend observations on their associations with
other SVD markers.
Our study conﬁrms that PVS are prevalent and severe in this
cohort of ischaemic stroke/TIA patients, consistent with other
studies.15 Multiple imaging markers of SVD have been inde-
pendently associated with cognitive decline in a range of clinical
cohorts, but only one study has investigated the association of
PVS with detailed cognitive testing. In this study of 97 healthy
elderly men, total PVS were signiﬁcantly associated with worse
non-verbal reasoning and visuospatial cognitive ability, after
adjusting for prior intelligence.5 Another recent population-
based study of healthy elderly (65–80 years) individuals found
that the highest severity degree of PVS was independently asso-
ciated with incident dementia during a 4-year follow-up period4
In our study, there were no suggestive trends or borderline asso-
ciations between PVS severity and cognitive impairment. It is
possible that no associations were noted because of the signiﬁ-
cant burden of symptomatic cerebrovascular disease in our
cohort including cortical infarcts, SVD and the high proportion
of patients with recurrent stroke. This could make it difﬁcult to
detect any independent contribution of PVS, in particular, if
they are an early feature of SVD. Indeed, some studies suggest
that PVS may precede other manifestations of SVD, for
example, WMH.16 17 Notwithstanding these limitations, our
data suggest that PVS do not have any major direct association
with cognition in this cohort. Further investigation of PVS and
Table 1 Multivariable regression analyses for basal ganglia and
centrum semiovale PVS severity
OR (95% CI) p Value
Basal Ganglia PVS
Age (for every 5-year increase) 1.18 (0.98 to 1.43) 0.081
Hypertension (yes vs no) 4.89 (1.39 to 17.21) 0.013
Median WMH score 1.27 (1.14 to 1.43) <0.0001
Lobar CMBs number 0.82 (0.42 to 1.60) 0.551
Deep CMBs number 1.77 (0.59 to 5.33) 0.312
Presence of lacunes 2.93 (1.10 to 7.84) 0.032
Centrum Semiovale PVS
Age (for every 5-year increase) 1.19 (1.04 to 1.37) 0.013
Hypertension (yes vs no) 3.71 (1.42 to 9.59) 0.007
Median WMH score 0.99 (0.89 to 1.10) 0.840
Lobar CMBs number 1.34 (0.60 to 2.95) 0.476
Number of lacunes 1.58 (0.45 to 5.57) 0.478
All the variables listed in the table have been used in the each multivariable model to
assess their independent effect on PVS severity in the respective anatomical location.
The results remain consistent after adjusting for transient ischaemic attack diagnosis
in the models.
Statistically significant results are in bold.
CI, confidence interval; OR, odds ratio; PVS, perivascular spaces; WMH, white matter
hyperintensities.
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cognition in larger cohorts without high cerebrovascular disease
burden (eg, healthy elderly cohorts) will help clarify this
hypothesis.
Our results strengthen the emerging link between PVS and
SVD. The strong relationship between basal ganglia PVS severity
and hypertension, WMH and small vessel occlusion-related
stroke type is in agreement with previous studies,15 18 and con-
sistent with the underlying pathophysiology being related to
intrinsic disease affecting deep perforating arteries (hypertensive
arteriopathy). The link between small vessel occlusion-related
stroke mechanism and higher basal ganglia PVS load also sup-
ports the hypothesis that basal ganglia PVS reﬂect the arteriopa-
thy underlying symptomatic small vessel occlusion-related stroke
(generally presumed to be hypertensive arteriopathy of deep
perforating vessels); SVD in the more eloquent deep white
matter is presumed more likely to cause symptomatic small
vessel occlusion-related infarcts. These ﬁndings thus consolidate
previous work suggesting a link between PVS severity and small
vessel occlusion-related stroke mechanism.8 11 Consistent with
our ﬁndings, previous studies in various populations, including
ischaemic subcortical and cortical stroke patients, have shown
that WMH are a signiﬁcant independent predictor of basal
ganglia PVS.18
The clinical-radiological factors associated with centrum semi-
ovale PVS were age and hypertension, but not WMH or small
vessel occlusion-related stroke subtype, suggesting that they may
have a different mechanism to basal ganglia PVS. CAA is one
possible mechanism since it affects cortical and leptomeningeal
arteries, which could impair interstitial ﬂuid drainage from
white matter to cortical areas.19 20
The main limitation of our study is its cross-sectional and
retrospective design, which restricts the analysis to the available
routinely collected information. A large number of patients
were excluded, leading to a young average age compared to
other stroke populations, and a rather high proportion of
patients with a recurrent stroke; this may have led to selection
bias. Another potential confounding variable in our cohort is
the high prevalence of hypertension (68.2%). These factors
could potentially limit the generalisation of our results to other
cohorts of patients with ischaemic stroke/TIA. Finally, due to
the use of retrospective routinely collected data, not all patients
had identical neuropsychological tests precluding the presenta-
tion of continuous data or z-scores.
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